03 Apr 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Quest Diagnostics, a diagnostic information service provider, appointed Dr Sukumar Nagendran, as vice president, medical affairs. In this role, Dr Nagendran will provide medical oversight for the company's diagnostic information services.
Dr Nagendran served as vice president and head of medical affairs at Reata Pharma. Prior to that, he was therapeuti-area head for new product development, medical affairs, clinical operations and biometrics, in which he oversaw several therapeutic areas, including oncology, cardiovascular disease and diabetes, for Daiichi Sankyo.
He has held other senior positions related to clinical development and medical affairs for Pfizer and Novartis. Dr Nagendran's research on cardiovascular disease, diabetes, oncology, pulmonary medicine and other areas of medicine has been published in a number of peer-reviewed publications, including Endocrine Practice, Current Medical Research & Opinion and Journal of Clinical Lipidology.
Dr Jon R Cohen, chief medical officer and senior VP, Quest Diagnostics, said that, "Dr Nagendran has an impressive record of successful medical affairs in several clinical areas as well as in new product and business development and clinical trial operations. These experiences, combined with his relationships with top medical and healthcare experts, will help us to engage medical opinion leaders, payers and clients in more productive dialogues about the composition and value of our services. These competencies are critical as our company strives to be more externally focused and responsive to market needs."